<DOC>
	<DOCNO>NCT00643825</DOCNO>
	<brief_summary>This study test hypothesis prolong adjuvant Temozolomide ( TMZ ) may delay relapse patient glioblastoma compare standard care consist observation brain MRI every 3 month rechallenging TMZ relapse ( Stop Go arm ) .</brief_summary>
	<brief_title>Prolonged Adjuvant Temozolomide v `` Stop &amp; Go '' Glioblastoma Patients</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>1 . Patients histologically confirm diagnosis GBM 2 . Availability pretreatment GBM tissue determine activation status MGMT gene mandatory strongly recommend 3 . Patients must receive radiation TMZ 6 week follow 6 month TMZ . Randomization perform within 6 week last chemotherapy . 4 . A brain MRI without PETScanmethionine must perform enrolment . 5 . Age ≥ 18 year 6 . Karnofsky Performance status ≥ 60 7 . Normal haematological function : ANC ≥ 1.5 x 109cells/l , platelet ≥ 100 x 109 cells/l 8 . Normal liver function : total bilirubin &lt; 1.5 x ULN , alkaline phosphatase transaminase ( ASAT/ALAT ) &lt; 2.5 time upper limit normal range 9 . Serum creatinine &lt; 1.5 x ULN 10 . Clinically normal cardiac function without history ischemic heart disease past 12 month . Absence cardiac insufficiency NYHA grade III IV , instable angina , arrhythmia 11 . No previous current malignancy ( except treat basal squamous cell skin carcinoma , cervix cancer situ carcinoma breast ) . 12 . All patient ( male female ) reproductive potential must use effective contraception . Females must negative serum pregnancy test entry study . 13 . Signed informed consent patient legal representative must obtain . All non inclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Temozolomide</keyword>
	<keyword>Phase II</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Glioblastoma</keyword>
	<keyword>Progression-free Survival</keyword>
</DOC>